Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults

European Journal of Endocrinology

Volumn 172, Issue 3, 2015, Pages 291-300

  Wang, Rui ^a   Hong, Jie ^a   Cao, Yanan ^a   Shi, Juan ^a   Gu, Weiqiong ^a   Ning, Guang ^a   Zhang, Yifei ^a   Wang, Weiqing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA 122; TRIACYLGLYCEROL; MICRORNA; MIRN122 MICRORNA, HUMAN;

ADULT; ARTICLE; BLOOD LEVEL; BODY FAT; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VALIDATION STUDY; WAIST HIP RATIO; YOUNG ADULT; BLOOD; GENETICS; PHYSIOLOGY;

ADULT; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MICRORNAS; OBESITY; YOUNG ADULT;

EID: 84923644436     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0867     Document Type: Article

References (35)

1. Lean ME, Han TS & Seidell JC. Impairment of health and quality of life in people with large waist circumference. Lancet 1998 351 853-856. (doi:10.1016/S0140-6736(97)10004-6)
2. Ogden CL, Carroll MD, Kit BK & Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. Journal of the American Medical Association 2012 307 483-490. (doi:10.1001/jama.2012.40)
3. Savage DB, Petersen KF & Shulman GI. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 2005 45 828-833. (doi:10.1161/01.HYP.0000163475.04421.e4)
4. Rosen ED & Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006 444 847-853. (doi:10.1038/ nature05483)
5. Bray GA & Tartaglia LA. Medicinal strategies in the treatment of obesity. Nature 2000 404 672-677. (doi:10.1038/35007544)
6. Couzin J. MicroRNAs make big impression in disease after disease. Science 2008 319 1782-1784. (doi:10.1126/science.319.5871.1782)
7. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De SimoneMet al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. European Heart Journal 2010 31 2765-2773. (doi:10.1093/ eurheartj/ehq167)
8. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet- Cordero A, Ebert BL, Mak RH, Ferrando AA et al. MicroRNA expression profiles classify human cancers. Nature 2005 435 834-838. (doi:10. 1038/nature03702)
9. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation Research 2010 107 810-817. (doi:10.1161/CIRCRESAHA. 110.226357)
10. Karolina DS, Tavintharan S, Armugam A, Sepramaniam S, Pek SL, Wong MT, Lim SC, Sum CF & Jeyaseelan K. Circulating miRNA profiles in patients with metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2012 97 E2271-E2276. (doi:10.1210/jc.2012-1996)
11. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A et al. Circulating microRNAs as stable blood-based markers for cancer detection. PNAS 2008 105 10513-10518. (doi:10.1073/pnas. 0804549105)
12. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 2008 18 997-1006. (doi:10.1038/cr.2008.282)
13. Xie H, Lim B & Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009 58 1050-1057. (doi:10.2337/db08-1299)
14. Xu P, Vernooy SY, Guo M & Hay BA. The Drosophila microRNA mir-14 suppresses cell death and is required for normal fat metabolism. Current Biology 2003 13 790-795. (doi:10.1016/S0960-9822(03)00250-1)
15. Teleman AA, Maitra S & Cohen SM. Drosophila lacking microRNA miR- 278 are defective in energy homeostasis. Genes and Development 2006 20 417-422. (doi:10.1101/gad.374406)
16. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, Heim MH & Stoffel M. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011 474 649-653. (doi:10.1038/nature10112)
17. Ortega FJ, Mercader JM, Catalan V, Moreno-Navarrete JM, Pueyo N, Sabater M, Gomez-Ambrosi J, Anglada R, Fernandez-Formoso JA, RicartWet al. Targeting the circulating microRNA signature of obesity. Clinical Chemistry 2013 59 781-792. (doi:10.1373/clinchem.2012. 195776)
18. Pescador N, Perez-Barba M, Ibarra JM, Corbaton A, Martinez-Larrad MT & Serrano-Rios M. Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. PLoS ONE 2013 8 e77251. (doi:10.1371/journal.pone.0077251)
19. Consulation WE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004 363 157-163. (doi:10.1016/S0140-6736(03)15268-3)
20. Shi J, Zhang Y, Gu W, Cui B, Xu M, Yan Q,Wang W, Ning G & Hong J. Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults. PLoS ONE 2012 7 e48777. (doi:10.1371/journal.pone.0048777)
21. Wang R, Hong J, Liu R, Chen M, Xu M, GuW, Zhang Y, Ma Q, Wang F, Shi J et al. SFRP5 acts as a mature adipocytemarker but not as a regulator in adipogenesis. Journal of Molecular Endocrinology 2014 53 405-415. (doi:10.1530/JME-14-0037)
22. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE & Galas DJ. Circulating microRNAs, potential biomarkers for druginduced liver injury. PNAS 2009 106 4402-4407. (doi:10.1073/pnas. 0813371106)
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/BF00280883)
24. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabolism 2006 3 87-98. (doi:10.1016/j.cmet.2006.01.005)
25. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M & Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005 438 685-689. (doi:10.1038/nature04303)
26. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjarn M, Hansen HF, Berger U et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008 452 896-899. (doi:10.1038/nature06783)
27. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ & Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007 9 654-659. (doi:10.1038/ncb1596)
28. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Koppel T, Jahantigh MN, Lutgens E et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signaling 2009 2 ra81. (doi:10.1126/ scisignal.2000610)
29. Hunter MP, IsmailN, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 2008 3 e3694. (doi:10.1371/journal.pone.0003694)
30. Turchinovich A, Weiz L, Langheinz A & Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Research 2011 39 7223-7233. (doi:10.1093/nar/gkr254)
31. Wang K, Zhang S, Weber J, Baxter D & Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Research 2010 38 7248-7259. (doi:10.1093/nar/gkq601)
32. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD & Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature Cell Biology 2011 13 423-433. (doi:10.1038/ncb2210)
33. Eichelser C, Stuckrath I, Muller V, Milde-Langosch K, Wikman H, Pantel K & Schwarzenbach H. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Oncotarget 2014 5 9650-9663.
34. Guduric-Fuchs J, O'Connor A, Camp B, O'Neill CL, Medina RJ & Simpson DA. Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics 2012 13 357. (doi:10.1186/1471-2164-13-357)
35. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008 3 e3148. (doi:10.1371/journal.pone.0003148)